tiprankstipranks
Perspective Therapeutics (CATX)
:CATX
US Market

Perspective Therapeutics (CATX) Income Statement

Compare
1,230 Followers

Perspective Therapeutics Income Statement

Last quarter (Q1 2024), Perspective Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q1, Perspective Therapeutics's net income was $-15.12M. See Perspective Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Jun 22Jun 21Jun 20
Total Revenue
$ 1.43M$ 7.10M$ 10.79M$ 10.05M$ 9.68M
Gross Profit
$ 1.43M$ 1.63M$ 4.62M$ 5.12M$ 5.12M
Operating Expenses
$ 42.38M$ 17.43M$ 12.01M$ 8.56M$ 8.60M
Depreciation and Amortization
$ 981.00K$ 344.00K$ 248.00K$ 9.00K$ 147.00K
EBITDA
$ -39.96M$ -14.84M$ -7.39M$ -3.43M$ -3.48M
Operating Income
$ -40.94M$ -15.18M$ -7.39M$ -3.44M$ -3.48M
Other Income/Expenses
$ 835.00K$ 512.00K$ 119.00K$ 50.00K$ 30.00K
Pretax Income
$ -40.11M$ -14.67M$ -7.27M$ -3.39M$ -3.45M
Net Income
$ -46.51M$ -14.67M$ -7.15M$ -3.19M$ -3.27M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.40$ -0.10$ -0.05$ -0.03$ -0.05
Diluted EPS
$ -1.40$ -0.10$ -0.05$ -0.03$ -0.05
Weighted Average Shares Outstanding
26.76M 142.10M 141.99M 103.84M 67.60M
Weighted Average Shares Outstanding (Diluted)
26.76M 142.10M 141.99M 103.84M 67.60M
Currency in USD

Perspective Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis